<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Cortical pyramidal neurons (layer 5 </th>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td><a href="https://brain-map.org/atlases-and-data/rnaseq" target="_blank">CS202210140_3100</a></td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > Glutamatergic > Cortical > Deep Layer</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>BCL11B (CTIP2), FEZF2, CRYM, TLE4, PCP4</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>[Neocortex (layer 5)](/brain-regions/cortex ), [Motor Cortex](/brain-regions/motor-cortex), [Prefrontal Cortex](/brain-regions/prefrontal-cortex)</td>
</tr>
<tr>
<td class="label">Vulnerable In</td>
<td>ALS (upper motor neuron subtype), [Frontotemporal Dementia](/diseases/ftd), [Alzheimer's Disease](/diseases/Alzheimer s)</td>
</tr>
<tr>
<td class="label">Cell Ontology ID</td>
<td>[CL:CL:0000598](https://purl.obolibrary.org/obo/CL_0000598), [CL:CL:1001571](https://purl.obolibrary.org/obo/CL_1001571), [CL:CL:4023041](https://purl.obolibrary.org/obo/CL_4023041)</td>
</tr>
<tr>
<td class="label">Cell Ontology ID</td>
<td>[CL:0000598](https://purl.obolibrary.org/obo/CL_0000598), [CL:1001571](https://purl.obolibrary.org/obo/CL_1001571), [CL:4023041](https://purl.obolibrary.org/obo/CL_4023041)</td>
</tr>
</table>
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Cortical pyramidal neurons (layer 5 </th>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td><a href="https://brain-map.org/atlases-and-data/rnaseq" target="_blank">CS202210140_3100</a></td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > Glutamatergic > Cortical > Deep Layer</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>BCL11B (CTIP2), FEZF2, CRYM, TLE4, PCP4</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>[Neocortex (layer 5)](/brain-regions/cortex ), [Motor Cortex](/brain-regions/motor-cortex), [Prefrontal Cortex](/brain-regions/prefrontal-cortex)</td>
</tr>
<tr>
<td class="label">Vulnerable In</td>
<td>ALS (upper motor neuron subtype), [Frontotemporal Dementia](/diseases/ftd), [Alzheimer's Disease](/diseases/Alzheimer s)</td>
</tr>
<tr>
<td class="label">Cell Ontology ID</td>
<td>[CL:CL:0000598](https://purl.obolibrary.org/obo/CL_0000598), [CL:CL:1001571](https://purl.obolibrary.org/obo/CL_1001571), [CL:CL:4023041](https://purl.obolibrary.org/obo/CL_4023041)</td>
</tr>
<tr>
<td class="label">Cell Ontology ID</td>
<td>[CL:0000598](https://purl.obolibrary.org/obo/CL_0000598), [CL:1001571](https://purl.obolibrary.org/obo/CL_1001571), [CL:4023041](https://purl.obolibrary.org/obo/CL_4023041)</td>
</tr>
</table>
Cortical Pyramidal Neurons (Layer 5) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Layer 5 (L5) pyramidal neurons are the primary output neurons of the cortex, integrating information from all cortical layers and transmitting it to subcortical targets including the spinal-cord, brainstem, thalamus, striatum, and contralateral cortex. They are the largest neurons in the cortex, with thick apical dendrites that extend to layer 1 and elaborate basal dendritic arbors in layer 5. L5 pyramidal neurons are essential for voluntary movement, decision-making, and sensorimotor integration. In motor-cortex, the largest L5 pyramidal neurons—Betz cells—are the upper motor neurons whose degeneration is a cardinal feature of als.
<!-- taxonomy-enrichment -->
<!-- multi-taxonomy-enrichment -->
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000598](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000598) | pyramidal neuron |
| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:0000598](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000598) | pyramidal neuron | Exact |
| Cell Ontology | [CL:1001571](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001571) | hippocampal pyramidal neuron | Exact |
| Cell Ontology | [CL:4023041](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023041) | L5 extratelencephalic projecting glutamatergic cortical neuron | Exact |
L5 pyramidal neurons comprise two molecularly and functionally distinct populations:
Pyramidal tract (PT) neurons (also called extratelencephalic or ET neurons) express BCL11B (CTIP2) and FEZF2 and project to subcortical targets—spinal cord, brainstem, thalamus, and superior colliculus. Betz cells are the largest PT neurons, with soma diameters reaching 60–100 μm in humans. PT neurons fire with prominent burst patterns driven by dendritic calcium spikes in their thick apical tufts, and they are the cortical neurons most directly responsible for motor command execution.
Intratelencephalic (IT) neurons express SATB2 and TLE4 (at moderate levels) and project bilaterally to other cortical areas and the striatum. IT neurons have thinner apical dendrites, regular-spiking firing patterns, and play a greater role in intracortical communication and sensory-motor integration.
A landmark 2024 study in Cell using single-nucleus RNA sequencing of ALS and FTLD motor cortex precisely mapped the cell-type-specific vulnerabilities and confirmed that PT neurons bearing the FEZF2+/BCL11B+ signature are selectively lost in ALS, while IT neurons show relative resilience.
L5 PT neurons exhibit a unique dual-compartment integration mode. Somatic inputs from local circuits and thalamus drive regular action potentials, while coincident input to the distal apical tuft (receiving feedback from higher cortical areas) can trigger dendritic calcium spikes—regenerative plateau potentials lasting 50–100 ms that dramatically boost firing. This apical amplification mechanism, gated by sst-interneurons and vip-interneurons, is thought to implement a cortical "matching" computation where bottom-up sensory signals are compared with top-down predictions. L5 IT neurons, in contrast, operate primarily in a regular-spiking mode without prominent dendritic calcium spikes.
In motor-cortex, L5 PT neurons form the corticospinal tract (CST), the principal pathway for voluntary movement. Betz cells send axons up to 1 meter long to synapse directly on spinal motor neurons (monosynaptic corticomotoneuronal connections), a feature particularly developed in primates and essential for fine dexterous hand movements. In prefrontal-cortex, L5 PT neurons project to the subthalamic-nucleus and brainstem and are critical for executive control, decision-making, and goal-directed behavior. L5 IT neurons, by forming dense bilateral corticostriatal projections, are essential for action selection through the basal-ganglia circuit.
ALS: The degeneration of L5 corticospinal (PT) neurons, including Betz cells, is a defining feature of ALS. The "dying-forward" hypothesis proposes that cortical motor neuron hyperexcitability drives excitotoxic damage to spinal motor neurons via excessive glutamate release. L5 PT neurons in ALS show early dendritic regression, spine loss, and increased synaptic excitation in presymptomatic stages. A 2024 single-cell dissection study confirmed selective loss of PT/Betz neurons alongside upregulation of stress-response genes in surviving L5 neurons.
FTD: In ftd, L5 pyramidal neurons in the prefrontal and anterior temporal cortex show tdp-43 inclusions and progressive degeneration, correlating with behavioral disinhibition and personality changes. The genetic overlap between ALS and FTD (particularly c9orf72 expansions) reflects shared vulnerability of L5 projection neuron [@lemon2008] populations across motor and frontal cortices.
alzheimers: In alzheimers, L5 pyramidal neurons accumulate neurofibrillary tangles and show synaptic loss, particularly in association cortices. A 2025 study identified distinct synaptic molecular signatures of L5 IT and PT neurons, with disease-associated genes showing differential enrichment between subtypes, suggesting cell-type-specific vulnerability mechanisms.
L5 pyramidal neuron-directed therapies are central to ALS treatment strategies. Riluzole, the first FDA-approved ALS drug, reduces glutamatergic excitotoxicity affecting corticospinal circuits. Anti-sense oligonucleotides (ASOs) targeting sod1-protein (tofersen) and c9orf72 aim to reduce toxic protein expression in both upper and lower motor neurons. Transcranial magnetic stimulation (TMS) of motor cortex is used diagnostically (to detect upper motor neuron dysfunction via central motor conduction time) and is being explored therapeutically to modulate L5 excitability.
Recent single-cell and single-nucleus RNA-seq studies have provided unprecedented molecular resolution of L5 pyramidal neuron vulnerability:
The selective vulnerability of L5 PT neurons has implications for therapeutic development:
The study of Cortical Pyramidal Neurons (Layer 5) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.